Boule Diagnostics – Changes in Nomination Committee’s proposal for election of Board members 2023
The notice to Boule Diagnostics AB’s annual general meeting 2023 was announced in a press release on April 4, 2023. The press release presented the nomination committee’s proposal for the election of board members. The election committee has now been informed that Jon Risfelt declined re-election. The nomination committee does not intend to nominate any additional members, which is why the board is proposed to consist of five members.
The updated proposal for the 2023 AGM means that the nomination committee proposes the re-election of board members Karin Dahllöf, Thomas Eklund, Emil Hjalmarsson, Yvonne Mårtensson and Torben Jørgensen and that Torben Jørgensen is proposed as chairman of the board for the time until the next AGM.
Information about the proposed board members can be found on Boule’s website.
For more information, please contact:
Ulf Hedlundh, Chairman of the Nomination Committee, ulf.hedlundh ”at” svolder.se, phone +46 (0)8 – 440 37 70
Jesper Söderqvist, CEO and Group President, Boule Diagnostics AB, phone +46 (0)70-689 05 90
Jan Benjaminson, CFO, Boule Diagnostics AB, phone +46 (0)70-666 93 88
About Boule Diagnostics AB (publ)
Boule Diagnostics AB is a global diagnostics company that develops, manufactures and markets instruments and consumable products for blood diagnostics. The company serves hospitals, clinics, laboratories and companies within blood diagnostics, in both human and veterinary hematology. The company operates via subsidiaries in Sweden, the USA, Mexico and Russia. The company products are sold globally primarily through distributors, supported by Boule’s own local sales and support personnel. The Boule shares are listed on Nasdaq Stockholm since 2011. http://www.boule.com
The information was submitted for publication, through the agency of the contact person set out above, at 09.30 CET on May 4, 2023.
Latest news
-
Boule Diagnostics – Inbjudan till presentation av Q4 2025 6 Feb, 2026
-
Boule Diagnostics – Invitation to presentation of the Q4 report 2025 6 Feb, 2026
-
Boule Diagnostics förnyar och utökar ett globalt leveransavtal 21 Jan, 2026
-
Boule Diagnostics Renews and Expands a Global Supply Agreement 21 Jan, 2026
-
Boule Diagnostics appoints Michael af Winklerfelt as new CFO 30 Dec, 2025
-
Boule Diagnostics utser Michael af Winklerfelt till CFO 30 Dec, 2025
-
Boule Diagnostics Selected as One of Three Providers in Nationwide Hematology Tender in Italy 22 Dec, 2025
-
Boule Diagnostics utvald som en av tre leverantörer i den nationella hematologiupphandlingen i Italien 22 Dec, 2025